TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of corneal perforation or need for TPK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: met need for contraception
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Satisfactory cases in intervention group
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LV end-diastolic volume (EDV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hand hygiene adherence at room entry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand hygiene adherence at room exit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC pain score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: rectus femoris tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 8-foot walking test time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-time sit-to-stand test time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSS disorganized thought subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Night-time fecal incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Biochemical pregnancy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pain at insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuation rate at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life measured by SGRQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reported exacerbations
Endpoint domain: Adverse events/effects
Primary endpoint: remission free of any AEs
Endpoint domain: Adverse events/effects
Primary endpoint: remission free of study drug-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: surgical skills proficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in neurologic functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Correct response rate
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Non-HDL cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: volatile sulfur compound (VSC) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight maintenance success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HDLc concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall success rate within 10 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior wall puncture rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual ST-segment deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decreased growth of white hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cramping scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PERMP scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RDQ scores at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete or near-complete recovery of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: UAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBCT-based gray density values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CT-based gray density values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary implant stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CT numbers at the level of the popliteal artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mean score for the depiction of trifurcation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Reduction in annualized risk of a cardiovascular event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Setting a quit date
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Smoking risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bicarbonate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Head Circumference z scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment adherence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hopelessness score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Catalase activity in erythrocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superoxide dismutase activity in lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increment from baseline SpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportions of patients without MF at 36 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of TTF therapy in GBM patients with cardiac pacemakers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validated pain assessment measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of Impaired Fasting Glucose (IFG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acceptance of care management services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Concordance between initial and final decision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in shape concerns
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma citrulline concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma arginine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Non-oxidative leucine disposal (NOLD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median prolapse domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of women requiring surgical intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: perception of other students' gambling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: risk‐taking performance on analog measures of gambling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of urethral symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in first-voided urine leukocyte counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Surgical Site Occurrence Post Infection (SSOPI)
Endpoint domain: Adverse events/effects
Primary endpoint: Reoperation
Endpoint domain: Adverse events/effects
Primary endpoint: Mean HRQoL for survivors
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dietary fat quality assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: health status utilities
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Stiffness score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular mortality and hospitalization for cardiovascular morbidity
Endpoint domain: Mortality/survival
Primary endpoint: plasma potassium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dyspepsia-related quality of life (DRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptom severity (SS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Nipple necrosis
Endpoint domain: Adverse events/effects
Primary endpoint: OST levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Canadian Cardiovascular Society (CCS) angina classification improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospital admissions for COPD
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Patients' Perceived Participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NIPS pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients requiring opioid analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete the sandbag piling task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of injection-related pain
Endpoint domain: Adverse events/effects
Primary endpoint: Time on supplemental oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atherogenicity of lipid, lipoprotein, and apoprotein profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of perineal and cervical lacerations
Endpoint domain: Adverse events/effects
Primary endpoint: use of the Kristeller maneuver
Endpoint domain: Adverse events/effects
Primary endpoint: duration of the second stage of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of ustekinumab vs etanercept
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: early postoperative fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Secondary resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: effects of aggressive management of dyslipidemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reduction in diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: reduction in vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Variation of VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV high frequency (HF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in IBS-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of underweight children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infant acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma bradykinin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrent bleeding rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dysphoric effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean valine requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MiPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glucose infusion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Medication therapy problems identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation rate of pharmacist recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in drug cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Thyrotropin level decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Free thyroxine level increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total triiodothyronine level increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: risk of leukemia
Endpoint domain: Adverse events/effects
Primary endpoint: median life-span
Endpoint domain: Mortality/survival
Primary endpoint: Storage mite sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: competence gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of test anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Success rate of self-administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of self-administration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time taken for administration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Nocturnal hypoglycemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean sensor glucose value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Success rate for cecal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin sensitivity (homeostasis model assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Monocyte expression of TNF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Monocyte expression of IL-1beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Conversion to conventional laparoscopy or open surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Data recording errors
Endpoint domain: Adverse events/effects
Primary endpoint: Mean costs per questionnaire
Endpoint domain: Resource use
Primary endpoint: Mean duration of an interview
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 26-50% improvement at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-2 mm elevation of the brow at six and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CS-PFP score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean number of stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modification of automatic negative thoughts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perioperative cardiovascular stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction rate of patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: KCCQ summary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MLHFQ summary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SCHFI summary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 7-year biochemical-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: WDR < 9.5 Gy/wk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ETS exposure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High adherence to RaDIANT intervention requirements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Perceived helpfulness of RaDIANT intervention activities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to continue intervention components
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Apoptosis rate of Ishikawa cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMPs expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of symptomatic and asymptomatic anastomotic leakages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fasting and postprandial glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Behavioral impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: allergen provocation test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of antibodies to bacterial DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in colonization (cfu)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of cases with > or = 200 cfu/hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: overall FDS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pharyngeal-phase FDS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of sexual function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: poor outcome after 90 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proper alignment of the drain tube with the upper esophageal opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visualization of patients' vocal cords
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean dural sac cross-sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AP dural sac diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality-of-life benefits
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Full scale IQ
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prosocial behavior scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maximal peak pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute impulses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported pain, soreness, and discomfort in the lower extremity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of recovery score (QoR-40)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Injury severity score (ISS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total relative cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Jumping ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endurance parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in FI frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FISS exceeding MCID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported physical and mental health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Strength (one-repetition maximum leg press)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global scores of photoaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Melanin index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erythema index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carotid bulb size estimation accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean Banff scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of moderate to severe rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Estimated survival rates at 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Estimated survival rates at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of severe anemia
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of presenting visual impairment in the 'better eye'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean logMAR BCVA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes